Neuronal antigens modulate the immune response associated with experimental autoimmune encephalomyelitis

Immunology and Cell Biology

Volumn 82, Issue 1, 2004, Pages 17-23

  Degano, Alicia L ^a   Ditamo, Yanina ^a   Roth, German A ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Autoimmunity; Experimental autoimmune encephalomyelitis; Myelin basic protein; Neuronal antigens

Indexed keywords

FREUND ADJUVANT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; MYELIN; MYELIN BASIC PROTEIN;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; NONHUMAN; RAT;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS; CELL DIVISION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNOGLOBULIN G; LEUKOCYTES, MONONUCLEAR; MYELIN BASIC PROTEINS; NEURONS; RATS; RATS, WISTAR; SYNAPTOSOMES;

ANIMALIA; BOVINAE;

EID: 1642275234     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2004.01200.x     Document Type: Article

References (28)

1. Paterson PY, Swanborg RH. Demyelinating diseases of the central and peripheral nervous system. In: Samter M, Talmage DW, Frank MM, Austen, KF, Claman, HN (eds) Immunological Diseases. Boston: Little, Brown and Company, 1988; 1877-916.
2. Wekerle H. T-cell autoimmunity in the central nervous system. Intervirology 1993; 35: 95-100.
3. Slavin DA, Bucher AE, Degano AL, Soria NW, Roth GA. Time course of biochemical and immunohistological alterations during experimental allergic encephalomyelitis. Neurochem. Int. 1996; 29: 597-605.
4. Maggio B, Cumar FA, Roth GA, Monferran CG, Fidelio GD. Neurochemical and model membrane studies in demyelinating diseases. Acta Neuropathol. (Berlin) 1983; 9: 71-85.
5. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 1998; 338: 278-85.
6. Degano AL, Roth GA. Passive transfer of experimental autoimmune encephalomyelitis in Wistar rats: dissociation of clinical symptoms and biochemical alterations. J. Neurosci. Res. 2000; 59: 283-90.
7. Smith T, Groom A, Zhu B, Turski L. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nature Med. 2000; 6: 62-6.
8. Pedraza LT, Roth GA, Cumar FA. Identification as synapsin of a synaptosomal protein immunoreacting with anti-myelin basic protein antiserum. J. Neurochem. 1988; 51: 413-20.
9. De Santis ML, Roth GA, Cumar FA. Cellular immune cross-reactivity between myelin basic protein and synapsin in rats with experimental allergic encephalomyelitis. J. Neurosci. Res. 1992; 31: 46-51.
10. De Santis ML, Roth GA. Experimental allergic encephalomyelitis, characterization of T lymphocytes that bind myelin basic protein and synapsin. J. Neurosci. Res. 1996; 43: 50-4.
11. Degano AL, Bucher AE, Roth GA. Suppression of acute experimental allergic encephalomyelitis by intraperitoneal administration of synaptosomal antigens. J. Neurosci. Res. 1998; 53: 187-94.
12. Bucher AE, Maccioni M, Rivero VE, Riera CM, Roth GA. Experimental autoimmune encephalomyelitis: antigen-induced inhibition of biochemical and immunohistological alterations. J. Neurosci. Res. 1996; 46: 367-74.
13. Rivero VE, Maccioni M, Bucher AE, Roth GA, Riera CM. Suppression of experimental autoimmune encephalomyelitis (EAE) by intraperitoneal administration of soluble myelin antigens in Wistar rats. J. Neuroimmunol. 1997; 72: 3-10.
14. Schiebler W, Jahn R, Doucet JP, Rothlein J, Greengard P. Characterization of synapsin 1 binding to small synaptic vesicles. J. Biol. Chem 1986; 261: 8383-90.
15. Staykova MA, Cowden WB, Willenborg DO. Macrophages and nitric oxide as the possible cellular and molecular basis for strain and gender differences in susceptibility to autoimmune central nervous system inflammation. Immunol. Cell Biol. 2002; 80: 188-97.
16. Rivero VE, Riera CM, Roth GA. Humoral response against myelin antigens in two strains of rats with different susceptibility to experimental allergic encephalomyelitis (EAE). Autoimmunity 1999; 29: 129-37.
17. Harrison LC, Hafler DA. Antigen-specific therapy for autoimmune disease. Curr. Opin. Immunol. 2000; 12: 704-11.
18. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989; 7: 145-73.
19. Saoudi A, Kuhn J, Huygen K et al. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur. J. Immunol. 1993; 23: 3096-103.
20. Gracie JA, Bradley JA. Interleukin-12 induces interferon-gamma-dependent switching f IgG alloantibody subclass. Eur. J. Immunol. 1996; 26: 1217-21.
21. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787-93.
22. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 1996; 17: 138-46.
23. Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 1995; 16: 34-8.
24. Saoudi A, Bernard I, Hoedemaekers A et al. Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats. J. Immunol. 1999; 162: 7189-97.
25. Maccioni M, Riera CM, Rivero VE. Peritoneal antigen-presenting cells pulsed in vivo with myelin basic protein induce the suppression of experimental autoimmune encephalomyelitis (EAE) in Wistar rats. J. Neuroimmunol. 1999; 96: 46-56.
26. Nicot A, Ratnakar PV, Ron Y, Chen CC, Elkabes S. Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction. Brain 2003; 126: 398-412.
27. Polak T, Schlaf G, Scholl U et al. Characterization of the human T cell response against the neuronal protein synapsin in patients with multiple sclerosis. J. Neuroimmunol. 2001; 115: 176-81.
28. Eikelenboom MJ, Petzold A, Lazeron RH et al. Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy. Neurology 2003; 60: 219-23.